CKAP2L and central nervous system cancer: We employed a variety of data fusion analyses, based on thousands of multiethnic tissue samples to improve the scientific rigor and credibility of our results, and further verified the expression of CKAP2L in collected clinical samples and commercial glioma cell lines (Figure 7).